The open index of psychedelic research

Altered States, Enhanced Potential: Psychedelics and Physical Performance

Qarni Z, Richard J

Altered States, Enhanced Potential: Psychedelics and Physical Performance

Qarni Z, Richard J

Effect of postoperative esketamine on depression after pancreatoduodenectomy: a randomized controlled trial.

Zhang B, Wang Z, Yu K +9

Esketamine for negative emotions and cognitive function in general anesthesia: a systematic review and meta-analysis.

Yang X, Qin J, Xu W

Intranasal Esketamine Versus Other Pharmacological Strategies in Treatment-Resistant Depression with High Suicide Risk: A Six-Month Naturalistic Study.

de Granda-Beltrán AM, Porras-Segovia A, Núñez-Arias D +5

EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changes

Jajcay N, Vejmola Č, Korčák J +10

Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach.

Lima Constantino J, Freimann TS, van Dalfsen JH +5

Comment on "Effect of Remimazolam or Propofol Combined With Esketamine on Anesthesia and Early Perioperative Neurocognitive Disorders in Patients Undergoing Thoracoscopic Partial Lung Resection: A Randomized Clinical Trial".

Chandrasekar S, M K RK, Kumar U

PreprintPsychedelics

Becoming a Psychedelic Therapist: A Professional Identity Journey

Pennell M, Freer C, Bennett-Levy J +1

ArticlePsychedelics

Space Oddity: microgravity as a neurocognitive catalyst for transformative consciousness experiences.

Nezami A, Ferre ER

The Impact of General Anesthetics on Postoperative Delirium: A Narrative Review Based on Clinical Randomized Controlled Trials from the Last Five Years.

Wu JN, Xu JH, Ge JY +2

Comparison of the effects of two drug combinations: ropivacaine-dexmedetomidine and ropivacaine-ketamine administered subcutaneously for postoperative pain control in patients with inguinal hernia: a double-blind clinical trial.

Shojaei R, Kamali A, Eghbali Z +1

ArticlePsilocybin

Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression.

Mingardi J, Molteni R, Bifari F

ArticlePsychedelics

Progressing from Simple to Multidimensional Models Towards a Biopsychosocial Framework of Addiction.

Regier PS

ArticlePsilocybin

The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review.

Raikkerus H, Bujour A, Kennedy M +1

Ketamine-Assisted Psychotherapy for Depression: A Survey of Current Practices, Rationales, and Future Directions.

Buchanan JH, Reynante B, Dinh MT +1

Functional outcomes with esketamine in treatment-resistant depression: A 6-month multicenter real-world study.

Guglielmo R, Olivola M, Inuggi A +9

Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression

Tobel T, Cone A, Choquette E +8

Comment on: prophylactic esketamine to reduce postpartum depression in primiparae.

Wang J, Zhu H, Yu JM

Prophylactic esketamine to reduce postpartum depression in primiparae: A multicentre, double-blind, randomised clinical trial.

Du W, Liu Z

Reply to: prophylactic esketamine to reduce postpartum depression in primiparae: A multicentre, double-blind, randomised clinical trial.

Chu T, Xu A, Gao F

ArticleMDMA

Clinical and non-clinical use of MDMA.

Kvam TM, Goksøyr IW, Stewart LH +3

ArticleMDMA

Shifting Patterns in Ecstasy Use: Increasing Detection of MDA in Forensic Seizures and Toxicological Cases in Southern Brazil.

Dos Santos BP, Pôrto VC, Birk L +4